Residents of the rural China had fewer healthcare facilities and resources than those residing in urban regions. In 2021, there were only **** hospital beds available per 1,000 people in the rural areas of China.

The average number of hospital beds available per 1,000 people in China was forecast to continuously increase between 2024 and 2029 by in total *** beds (+***** percent). After the eighth consecutive increasing year, the number of available beds per 1,000 people is estimated to reach **** beds and therefore a new peak in 2029. Depicted is the number of hospital beds per capita in the country or region at hand. As defined by World Bank this includes inpatient beds in general, specialized, public and private hospitals as well as rehabilitation centers.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to *** countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the average number of hospital beds available per 1,000 people in countries like Japan and South Korea.

The average for 2020 based on 36 countries was 4.44 hospital beds. The highest value was in South Korea: 12.65 hospital beds and the lowest value was in Mexico: 0.99 hospital beds. The indicator is available from 1960 to 2021. Below is a chart for all countries where data are available.

In 2023, there were **** physicians and **** registered nurses serving every 1,000 inhabitants in Chinese urban areas, while the density of healthcare personnel was significantly lower in the countryside. Although China has more than a million healthcare facilities nationwide, structural inequalities between health services in urban and rural areas remain a long-term challenge.

This study applied the non-parametric four-stage data envelopment analysis method (Four-Stage DEA) to measure the relative efficiencies of Chinese public hospitals from 2010 to 2016, and to determine how efficiencies were affected by eight factors. A sample of public hospitals (n = 84) was selected from Chongqing, China, including general hospitals and traditional Chinese medicine hospitals graded level 2 or above. The Four-Stage-DEA method was chosen since it enables the control of the impact of environment factors on efficiency evaluation results. Data on the number of staff, government financial subsidies, the number of beds and fixed assets were used as input whereas the number of out-patients and emergency department patients and visits, the number of discharged patients, medical and health service income and hospital bed utilization rate were chosen as study outputs. As relevant environmental variables, we selected GDP per capita, permanent population, population density, number of hospitals and number of available sickbeds in local medical institutions. The relative efficiencies (i.e. technical, pure technical, scale) of sample hospitals were also calculated to analyze the change between the first stage and fourth stage every year. The study found that Four-Stage-DEA can effectively filter the impact of environmental factors on evaluation results, which sets it apart from other models commonly used in existing studies.

The average number of hospital beds available per 1,000 people in Japan was forecast to continuously decrease between 2024 and 2029 by in total *** beds (-*** percent). After the fifteenth consecutive decreasing year, the number of available beds per 1,000 people is estimated to reach ***** beds and therefore a new minimum in 2029. Depicted is the number of hospital beds per capita in the country or region at hand. As defined by World Bank this includes inpatient beds in general, specialized, public and private hospitals as well as rehabilitation centers.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to *** countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the average number of hospital beds available per 1,000 people in countries like China and South Korea.

BackgroundRegional disparities in healthcare resource allocation across space and time present significant challenges to the global achievement of SDG 3, SDG 10, and SDG 11. To this end, we proposed a joint spatiotemporal evaluation framework to assess the synergistic efficiency of multiple healthcare resources.MethodsUsing China as a case study, we analyzed data from 365 cities (2000–2021) on three key healthcare resource indicators: hospitals, hospital beds, and physicians. A composite healthcare resource score was constructed using the entropy weight method. We developed a three-dimensional joint spatiotemporal evaluation framework incorporating spatial Gini coefficient, emerging hotspot analysis, and Bayesian spatiotemporally varying coefficients (BSTVC) model with spatiotemporal variance partitioning index (STVPI) to evaluate spatiotemporal equity, agglomeration, and influencing factors. Individual indicators were evaluated to validate the framework’s robustness.Results(i) Spatiotemporal description: The composite indicator, weighted by hospitals (25%), hospital beds (46%), and physicians (29%), showed only a modest increase from 2000 to 2021, with persistently lower values in western and northern regions. (ii) Common spatiotemporal equity: The spatial Gini coefficient for the composite indicator increased annually by 0.34%, mirroring trends in hospital beds (0.34%) and physicians (0.26%) but contrasting with hospitals (−0.32%). This suggested that declining equity was mainly driven by hospital beds and physicians, partially offset by the more balanced distribution of hospitals. (iii) Common spatiotemporal agglomeration: Hotspot intensity for the composite indicator was lower than that for hospitals but higher than that for hospital beds and physicians. Cold spots were more concentrated for the composite indicator than for any individual indicator, with less than 10% overlap across the three indicators, indicating weak regional synergy. (iv) Common spatiotemporal drivers: BSTVC and STVPI methods revealed consistent patterns of explainable percentages across four healthcare resource indicators, with population density (37.96%, 95% CI: 30.05–43.05%) and employed population density (31.63%, 30.69–33.83%) emerging as dominant common drivers, supporting unified and coordinated policy interventions.DiscussionWe proposed a joint spatiotemporal evaluation framework to quantify both common and differentiated allocation patterns and driving factors across multiple healthcare resource indicators, highlighting the necessity for type-specific, temporally responsive, and spatially adaptive interventions to support dynamic monitoring and precise regulation of regional healthcare resource allocation globally.

Yearly citation counts for the publication titled "Medical condition, population density, and residents’ savings in China’s contiguous destitute areas".

Definitions and data source of input/output metrics and environmental variables.

Explore the booming HDI PCB for Medical Devices market! Discover market size, CAGR, growth drivers, restraints, key applications (portable, implantable, surgical), and leading companies shaping the future of healthcare technology.

Adjusted result of original input for Stage 3 from 2010 to 2016.

Descriptive statistics of inputs/outputs variables from 2010 to 2016.

Intravenous Fluid Bags Market Outlook

According to our latest research, the Global Intravenous Fluid Bags market size was valued at $3.4 billion in 2024 and is projected to reach $6.1 billion by 2033, expanding at a robust CAGR of 6.8% during the forecast period of 2025–2033. A primary driver of this substantial growth is the increasing prevalence of chronic diseases and the rising number of surgical procedures globally, which has significantly boosted the demand for intravenous (IV) therapy in both acute and chronic care settings. The market is also benefiting from advancements in material science, leading to the development of safer and more durable IV fluid bags, further propelling adoption across a wide spectrum of healthcare facilities.

Regional Outlook

North America currently holds the largest share of the global intravenous fluid bags market, accounting for approximately 36% of the total market value in 2024. This dominance can be attributed to the region’s highly developed healthcare infrastructure, widespread adoption of advanced medical technologies, and a strong focus on patient safety. The presence of leading industry players and stringent regulatory standards for medical devices have fostered a mature and competitive market environment. Additionally, the high incidence of lifestyle-related disorders and chronic illnesses such as diabetes and cardiovascular diseases in the United States and Canada has led to a steady increase in hospital admissions, thereby fueling consistent demand for IV fluid bags. Reimbursement policies and government initiatives aimed at improving healthcare delivery further reinforce the region’s leadership position in the global market.

The Asia Pacific region is poised to be the fastest-growing market for intravenous fluid bags, projected to register a remarkable CAGR of 8.2% between 2025 and 2033. This growth trajectory is driven by rising healthcare expenditure, rapid urbanization, and an expanding patient pool due to increasing population density in countries like China, India, and Japan. Government investments in healthcare infrastructure and the proliferation of private hospitals are fostering greater access to advanced medical treatments, including IV therapy. Moreover, the region is witnessing a surge in partnerships between local manufacturers and international players, facilitating technology transfer and the introduction of innovative products tailored to regional needs. The Asia Pacific market’s dynamism is further enhanced by favorable regulatory reforms and a growing emphasis on quality standards in medical consumables.

Emerging economies in Latin America and the Middle East & Africa are experiencing gradual but steady market growth, albeit at a slower pace compared to developed regions. The adoption of intravenous fluid bags in these areas is often hampered by challenges such as limited healthcare infrastructure, lower healthcare spending, and regulatory bottlenecks. However, localized demand is being driven by the increasing burden of infectious diseases and maternal health issues, prompting governments and NGOs to prioritize improvements in basic healthcare delivery. Efforts to streamline procurement processes, coupled with targeted awareness campaigns and training programs for healthcare professionals, are gradually improving market penetration. Despite these advances, the pace of adoption remains uneven, highlighting the need for tailored strategies to address region-specific barriers and capitalize on latent growth opportunities.

Report Scope

Descriptive statistics of environment variables from 2010 to 2016.

Relative efficiency and frequency distribution of sampled hospitals at Stage 1 from 2010 to 2016.

Snapshot img

Womens Health Diagnostics Market Size 2024-2028

The womens health diagnostics market size is forecast to increase by USD 14.61 billion at a CAGR of 8.09% between 2023 and 2028.

The women's health diagnostics market is experiencing significant growth due to several key factors. The increasing prevalence of breast cancer worldwide is driving market demand, as early and accurate medical diagnostics is crucial for effective treatment. 
Another trend is the global adoption of advanced diagnostic solutions, which offer improved accuracy and efficiency compared to traditional methods. Stringent regulatory bodies are also guiding manufacturers of in-vitro diagnostics to ensure product safety and quality, further boosting market growth. These factors are expected to continue shaping the women's health diagnostics market In the coming years.

What will be the Size of the Womens Health Diagnostics Market During the Forecast Period?

Request Free Sample

The Women's Health Diagnostics Market encompasses a range of medical diagnostic devices and techniques aimed at detecting various conditions unique to women. Key diseases include breast, ovarian, and cervical cancers, as well as infectious diseases such as hepatitis and urinary tract infections. Diagnostic methods span imaging techniques like Breast MRI and ultrasound, bone density testing for osteoporosis, and breast cancer biopsy devices for cancer diagnosis. 
The geriatric female population is a significant market driver, given the increased prevalence of chronic conditions like cancer and osteoporosis. Medical science continues to advance, leading to the development of more sophisticated diagnostic tools and tests for pregnancy and menopause.
The market also caters to infectious diseases, with a growing focus on HIV/AIDS and other sexually transmitted infections. Overall, the Women's Health Diagnostics market is a vital sector in healthcare, providing essential tools for early detection and effective treatment of various conditions.

How is this Womens Health Diagnostics Industry segmented and which is the largest segment?

The womens health diagnostics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Breast cancer testing
  Infectious disease testing
  STD testing
  Cervical cancer testing
  Others


End-user

  Hospitals and clinics
  Diagnostic and imaging centers
  Home care settings


Geography

  North America

    Canada
    US


  Europe

    UK
    France


  Asia

    China


  Rest of World (ROW)

By Application Insights

The breast cancer testing segment is estimated to witness significant growth during the forecast period.

Women's health diagnostics encompass various medical tests and devices used to identify and manage conditions such as breast cancer, ovarian cancer, cervical cancer, menopause, pregnancy, and chronic conditions like osteoporosis and infectious diseases. Breast cancer diagnosis primarily relies on biopsy procedures, where a specialized needle and imaging techniques, such as mammography or ultrasound, guide the doctor to extract tissue samples for laboratory analysis. Biopsy devices, ultrasound devices, mammography systems, and diagnostic tests are essential medical diagnostics tools. The geriatric female population, hospitals and clinics, diagnostic centers, and home care settings utilize these devices. Diagnostic tests for breast cancer, cervical cancer, ovarian cancer, prenatal genetic screening, and infectious diseases like hepatitis, urinary tract infection, and HIV/AIDS are crucial.

Medical science advances continue to introduce new technologies, such as bone density testing, MRI, and genomic testing, to enhance diagnostic accuracy and patient care. Healthcare expenditure on diagnostic devices, accessories, and consumables is significant, with emerging countries increasingly investing in these technologies.

Get a glance at the Womens Health Diagnostics Industry report of share of various segments Request Free Sample

The Breast cancer testing segment was valued at USD 6.56 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

In North America, the adoption of advanced diagnostic technologies for women's health has been on the rise due to increasing healthcare expenditure, growing awareness about chronic diseases such as breast, ovarian, and cervical cancer, and the availability

Regression analysis of environmental factors and input slack variables for Stage 2 from 2010 to2016.

Comparison between the relative efficiencies calculated by Four-Stage-DEA during step1 and step 4 during 2010–2016.

The allocation of medical resources is usually inappropriate in China because it is mainly based on the population of each administrative area. In real life, individual patients make choices based on numerous other factors, such as the quality of medical service, the service capacity of certain hospitals and their own income level. This study aims to reveal the differences between theoretical medical resource allocation and the actual medical treatment choices of liver cancer patients in Shenzhen, China, based on case data from 2010 to 2012. Two categories with six group maps are used to illustrate this situation, including independent charts and analytical method-based thematic maps. Meaningful conclusions are then proposed to improve medical resource allocation.

BackgroundHealthcare-associated infections (HAIs) are a significant concern in infection prevention. This study analyzes the trend of incidence of HAIs in a tertiary care hospital in China and assesses the effectiveness of cluster based interventions.MethodsA retrospective analysis was conducted on HAIs reports from 2015 to 2024, focusing on episodes involving the incidence rate of hospital infections, the catheter infection rate related to invasive procedures in the intensive care unit (ICU), healthcare workers’ compliance with hand hygiene, needlestick and sharp injuries (NSIs) among healthcare workers, the prophylactic use rate of antimicrobial agents for Class I surgical incisions, and the antimicrobial usage density (AUD). In 2019, we implemented cluster-based interventions on the incidence of HAIs, strengthening hospital infection control.ResultsThe downward trend in HAIs is notable, with infection rates of 9.34 ± 0.25 and 7.29 ± 0.78 per 1,000 patient-days observed during the periods of 2015–2019 and 2020–2024, respectively (p